Immunodiagnostic Systems (IDH) Share Price, News & Analysis

Company Overview

Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: 378 to 378
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 14,539 shs
• Market Capitalization: £108.80 million
• P/E Ratio: 290.77
• Dividend Yield: 0.50%
• Price Target: N/A
• Consensus Rating: N/A

IDH Stock Analysis - Frequently Asked Questions

How were Immunodiagnostic Systems' earnings last quarter?

Immunodiagnostic Systems Holdings PLC (LON:IDH) posted its quarterly earnings results on Wednesday, June, 20th. The company reported $5.70 earnings per share for the quarter, topping the consensus estimate of $2.60 by $3.10.

How do I buy shares of Immunodiagnostic Systems?

Shares of IDH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Immunodiagnostic Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH), iShares Biotechnology ETF (IBB), Redrow (RDW), Netflix (NFLX), Sysco (SYY), TP ICAP Group (TCAP) and Telford Homes (TEF).

Company Calendar

• Last Earnings: 6/20/2018
• Today: 5/30/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Appliances & Equipment
• Sub-Industry: N/A
• Current Symbol: LON:IDH
• CIK: N/A
• Web: www.idsplc.com
• Phone: +44-191-5190660
• Fax: N/A
• Employees: 147,000
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 290.77
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 6.84
• Current Ratio: 5.40
• Quick Ratio: 3.87

Sales & Book Value

• Annual Sales: £34.25 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 4.50
• Book Value: GBX 187.60 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 28,784,000
• Free Float: N/A
• Market Cap: £108.80 million
• Optionable: Not Optionable
• Beta: N/A